Journal:JMedChem:1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (11:27, 22 June 2022) (edit) (undo)
 
(16 intermediate revisions not shown.)
Line 1: Line 1:
-
<StructureSection load='Estr1.pdb' size='500' side='right' scene='Journal:JMEDCHEM:1/Cv/2' caption=''>
+
<StructureSection load='Estr1.pdb' size='450' side='right' scene='Journal:JMEDCHEM:1/Cv/2' caption=''>
=== Structure of estradiol metal chelate and estrogen receptor complex: The basis for designing a new class of SERMs ===
=== Structure of estradiol metal chelate and estrogen receptor complex: The basis for designing a new class of SERMs ===
-
<big>Min-Jun Li, Harry M Greenblatt, Orly Dym, Shira Albeck, Adi Pais, Chidambaram Gunanathan, David Milstein, Hadassa Degani, and Joel L. Sussman</big>
+
<big>Min-Jun Li, Harry M. Greenblatt, Orly Dym, Shira Albeck, Adi Pais, Chidambaram Gunanathan, David Milstein, Hadassa Degani, and Joel L. Sussman</big> <ref>PMID: 21473635</ref>
<hr/>
<hr/>
<b>Molecular Tour</b><br>
<b>Molecular Tour</b><br>
-
Selective <scene name='Journal:JMEDCHEM:1/Cv/3'>estrogen receptor</scene> modulators, such as estradiol 17-derived metal complexes, have been synthesized as targeted probes for the diagnosis and treatment of breast cancer. Here, we report the detailed 3D structure of estrogen receptor α ligand-binding domain (ER-LBD) bound with a novel <scene name='Journal:JMEDCHEM:1/Cv/5'>estradiol-derived metal complex, estradiol-pyridinium tetra acetate europium (III) (EPTA-Eu)</scene> at 2.6 resolution. The residues <scene name='Journal:JMEDCHEM:1/Cv/6'>Glu353, Arg394 and His524 and the conserved water molecule (W1006) form hydrogen bonds</scene> with estrogen receptor. <scene name='Journal:JMEDCHEM:1/Cv/7'>Superposition</scene> of this structure with the structure of native ligand 17β-estradiol (E2) in the complex of E2/ERα-LBD complex ([[1ere]]) reveals that the <scene name='Journal:JMEDCHEM:1/Cv/8'>E2 core of EPTA-Eu overlaps closely with that of E2 itself</scene>. <scene name='Journal:JMEDCHEM:1/Al/3'>Superposition</scene> of EEu/ERα-LBD complex on OHT/ERα-LBD complex ([[3ert]]). <scene name='Journal:JMEDCHEM:1/Al/4'>There are no hydrogen bonds formed between OHT</scene> and residues in H3, H7-H8 and H11 within the OHT/ERα-LBD complex. This structure provides important information pertinent to the design of novel functional ER targeted probes for clinical applications.
+
Selective estrogen receptor modulators, such as estradiol 17-derived metal complexes, have been synthesized as targeted probes for the diagnosis and treatment of breast cancer. Here, we report the detailed 3D structure of <scene name='Journal:JMEDCHEM:1/Cv/11'>estrogen receptor alpha ligand-binding domain (ER-LBD)</scene> bound with a novel <scene name='Journal:JMEDCHEM:1/Cv/5'>estradiol-derived metal complex, estradiol-pyridinium tetra acetate europium (III) (EPTA-Eu)</scene> at 2.6 resolution. The residues <scene name='Journal:JMEDCHEM:1/Cv/10'>Glu353, Arg394 and His524 and the conserved water molecule (W1006) form hydrogen bonds</scene> with EPTA-Eu. The hydrogen bonds are shown as white dashed lines. <scene name='Journal:JMEDCHEM:1/Cv/7'>Superposition</scene> of this structure with the structure of native ligand 17β-estradiol (E2) in the complex of E2/ERα-LBD complex ([[1ere]]) reveals that the <scene name='Journal:JMEDCHEM:1/Cv/12'>E2 core of EPTA-Eu overlaps closely with that of E2 itself</scene>. The <scene name='Journal:JMEDCHEM:1/Cv/9'>hydrogen bonds network</scene> made by additional estrogen receptor residues (''e.g.'' Glu419 of H7 and Glu339 of H3, this depends on subunit), may work together with the E2 17β hydroxyl-His524 hydrogen bond and tighten the neck of the LBP upon binding of the endogenous ligand E2. 4-Hydroxytamoxifen (OHT) is an other selective estrogen receptor modulator. <scene name='Journal:JMEDCHEM:1/Al/5'>Superposition</scene> of EPTA-Eu/ERα-LBD complex on OHT/ERα-LBD complex ([[3ert]]) shows that there is similar network of hydrogen bonds in both complexes, except for His524 which does not form hydrogen bond with OHT in the OHT/ERα-LBD complex. <scene name='Journal:JMEDCHEM:1/Al1/3'>Superposition of structures of all these three complexes:</scene> E2/ERα-LBD ([[1ere]]), OHT/ERα-LBD ([[3ert]]) and EPTA-Eu/ERα-LBD shows that they overlap well in the majority portions of the domain, but differ significantly in the region of the 'omega loop'. They display different synergistic reciprocating movements, depending on the specific nature of the ligand bound. The structure of estrogen receptor complexed with EPTA-Eu provides important information pertinent to the design of novel functional ER targeted probes for clinical applications.
 +
'''PDB reference:''' Crystal structure of estradiol derived metal chelate and estrogen receptor-ligand binding domain complex, [[2yat]].
</StructureSection>
</StructureSection>
<references/>
<references/>
__NOEDITSECTION__
__NOEDITSECTION__

Current revision

Drag the structure with the mouse to rotate
  1. Li MJ, Greenblatt HM, Dym O, Albeck S, Pais A, Gunanathan C, Milstein D, Degani H, Sussman JL. Structure of estradiol metal chelate and estrogen receptor complex: The basis for designing a new class of selective estrogen receptor modulators. J Med Chem. 2011 Apr 7. PMID:21473635 doi:10.1021/jm200192y

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Jaime Prilusky

This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.
Personal tools